Sniderman, Allan D.

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study

McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet

Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors

Cited by 864

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 659

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., & Ference, B. A. (2019) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 593

Why might south asians be so susceptible to central obesity and its atherogenic consequences? the adipose tissue overflow hypothesis

Sniderman, A. D., Bhopal, R., Prabhakaran, D., Sarrafzadegan, N., & Tchernof, A. (2007) · International Journal of Epidemiology

Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

Cited by 343

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.

SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 266

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 262

Quantifying importance of major risk factors for coronary heart disease

Pencina, M. J., Navar, A. M., Wojdyla, D., Sanchez, R. J., Khan, I., Elassal, J., D’Agostino, R. B., Peterson, E. D., & Sniderman, A. D. (2019) · Circulation

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 247

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 224

Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification

Wilkins, J. T., Li, R. C., Sniderman, A., Chan, C., & Lloyd-Jones, D. M. (2016) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCardiac Imaging and Diagnostics

Cited by 181

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C

Pencina, M. J., D’Agostino, R. B., Zdrojewski, T., Williams, K., Thanassoulis, G., Furberg, C. D., Peterson, E. D., Vasan, R. S., & Sniderman, A. D. (2015) · European Journal of Preventive Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 164

Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials

Thanassoulis, G., Williams, K., Ye, K., Brook, R., Couture, P., Lawler, P. R., de Graaf, J., Furberg, C. D., & Sniderman, A. (2014) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 148

Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention

Sniderman, A. D., Dufresne, L., Pencina, K. M., Bilgic, S., Thanassoulis, G., & Pencina, M. J. (2024) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 139

Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Sniderman, A. D., Islam, S., Yusuf, S., & McQueen, M. J. (2012) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 138

Reliability of low-density lipoprotein cholesterol, non-high density lipoprotein cholesterol, and apolipoprotein B measurement

Contois, J. H., Warnick, G. R., & Sniderman, A. D. (2011) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthClinical Laboratory Practices and Quality Control

Cited by 123

Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women

Lawler, P. R., Akinkuolie, A. O., Ridker, P. M., Sniderman, A. D., Buring, J. E., Glynn, R. J., Chasman, D. I., & Mora, S. (2017) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 104

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula

Sniderman, A. D., Blank, D., Zakarian, R., Bergeron, J., & Frohlich, J. (2003) · Clinical Biochemistry

MicroRNA in disease regulationRetinal Diseases and Treatments

Cited by 100

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf, J., Couture, P., & Sniderman, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 80

Editorial

Sniderman, A. D., Pedersen, T., & Kjekshus, J. (1997) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 57

Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3

van Oostrom, A. J., van Dijk, H., Verseyden, C., Sniderman, A. D., Cianflone, K., Rabelink, T. J., & Castro Cabezas, M. (2004) · The American Journal of Clinical Nutrition

Adipokines, Inflammation, and Metabolic DiseasesLipid metabolism and disorders

Cited by 53

The clinical utility of apoB versus LDL-C/non-HDL-C

Kohli-Lynch, C. N., Thanassoulis, G., Moran, A. E., & Sniderman, A. D. (2020) · Clinica Chimica Acta

Lipoproteins and Cardiovascular HealthClinical Laboratory Practices and Quality Control

Cited by 47

World Heart Federation Cholesterol Roadmap

Murphy, A., Faria-Neto, J. R., Al-Rasadi, K., Blom, D., Catapano, A., Cuevas, A., Lopez-Jimenez, F., Perel, P., Santos, R., Sniderman, A., et al. (2017) · Global Heart

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 43

Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)

Pallazola, V. A., Sathiyakumar, V., Park, J., Vakil, R. M., Toth, P., Lazo-Elizondo, M., Brown, E., Quispe, R., Guallar, E., Banach, M., et al. (2020) · Archives of Medical Science

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 38

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB

Sniderman, A. D., Toth, P. P., Thanassoulis, G., & Furberg, C. D. (2016) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 31

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Sniderman, A. D. (2019) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 23